Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 241

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 241
---
), (ii) 5,000Non-tradeable Warrants, and (iii) 7,750Tradeable Warrants.

On July 25, 2023, the Company converted 2,162shares of Series A Preferred Stock held by Knight into 3,797shares of common stock.

On January 29, 2024, the Company, entered into an Underwriting Agreement with WallachBeth Capital LLC (the “Underwriting Agreement”), relating to the Company’s public offering (the “January 2024 Offering”) of 438,409units (the “Units”) at an offering price of $ 4.62per Unit and 83,259pre-funded units (the “Pre-Funded Units”) at an offering price of $ 4.50per Pre-Funded Unit. Each Unit consisted of oneshare of common stock and onewarrant exercisable for oneshare of common stock (the “January 2024 Warrants”). Each January 2024 Warrant has an exercise price of $ 5.082per share ( 110% of the offering price per Unit), was exercisable immediately upon issuance and expires five yearsfrom the date of issuance. Each Pre-Funded Unit consists of onepre-funded warrant exercisable for oneshare of common stock (the “January 2024 Pre-Funded Warrants”) and onewarrant identical to the January 2024 Warrants included in the Units. The purchase price of each Pre-Funded Unit was equal to the price per Unit sold to the public in the offering, minus $ 0.12, and the exercise price of each January 2024 Pre-Funded Warrant is $ 0.12per share. The January 2024 Pre-Funded Warrants were immediately exercisable and may be exercised at any time until exercised in full.

F-18 The Company granted WallachBeth Capital LLC an option, exercisable within 45 days after the closing of the offering, to purchase up to 65,762shares of the Company’s common stock at a price of $ 4.62per share and/or 78,250January 2024 Warrants at a price of $ 0.12per warrant and/or 12,489January 2024 Pre-Funded Warrants at a price of $ 4.50per pre-funded warrant, or any combination of additional shares of common stock, January 2024 Warrants and/or January 2024 Pre-Funded Warrants, representing, in